Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration symbols : Cdxs save search
Codexis and Molecular Assemblies Announce Results of First Collaboration on a Proprietary High Performing DNA Polymerase to Supercharge Fully Enzymatic DNA Synthesis
Published: 2022-04-12 (Crawled : 18:00) - biospace.com/
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: 2.12%
H: 4.51%
C: -2.28%
collaboration results molecular
The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc.
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: 0.71%
H: 0.0%
C: 0.0%
collaboration molecular
Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost Sitagliptin API for the Generic Market, Including a License to Codexis Enzyme Technology in India
Published: 2021-10-18 (Crawled : 12:15) - globenewswire.com
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: -0.49%
H: 1.67%
C: -1.28%
collaboration india license technology
Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient
Published: 2021-08-02 (Crawled : 12:15) - globenewswire.com
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: -0.19%
H: 0.7%
C: -0.19%
collaboration
Five Collaborations Unlocking Faster Drug Development this Week
Published: 2021-06-10 (Crawled : 15:00) - biospace.com/
MNKD | $4.19 2.7% 2.63% 1.8M
|
Health Technology
|
| O: 0.98%
H: 0.73%
C: -2.18%
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: -0.05%
H: 4.39%
C: 3.16%
collaboration drug
Codexis and Takeda Expand Strategic Collaboration and License Agreement to Discover Additional Gene Therapy for a Fourth Rare Genetic Disorder
Published: 2021-06-10 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.35%
H: 1.75%
C: 1.34%
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: -0.05%
H: 4.39%
C: 3.16%
genetic gene therapy therapy collaboration license gene therapies rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.